Wellington Management Group’s NextCure NXTC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-2,012
Closed -$193K 2234
2021
Q2
$193K Sell
2,012
-122
-6% -$12.5K ﹤0.01% 2094
2021
Q1
$256K Sell
2,134
-1,454
-41% -$211K ﹤0.01% 2023
2020
Q4
$469K Sell
3,588
-28,244
-89% -$3.65M ﹤0.01% 1727
2020
Q3
$3.36M Sell
31,832
-7,995
-20% -$983K ﹤0.01% 1333
2020
Q2
$10.2M Sell
39,827
-3,997
-9% -$1.52M ﹤0.01% 1061
2020
Q1
$19.5M Sell
43,824
-5,544
-11% -$2.96M 0.01% 881
2019
Q4
$33.4M Buy
+49,368
New +$24.8M 0.01% 862
2019
Q3
Sell
-2,099
Closed -$378K 2088
2019
Q2
$378K Buy
+2,099
New +$436K ﹤0.01% 1947

Other funds holding NXTC

Wellington Management Group's NXTC Position: Q3 2021 in Review

Wellington Management Group sold out of NextCure (NXTC) in Q3 2021, closing a stake of 2,012 shares — an estimated $193K sold.

Wellington Management Group first reported a position in NXTC in Q2 2019 and held it in 8 quarters. The position peaked at $33.4M in Q4 2019. 71 funds tracked by Wall St. Rank hold NXTC as of Q3 2021.

  • Wellington Management Group reported no remaining NextCure position as of Q3 2021 after selling out during the quarter.
  • Wellington Management Group sold 2,012 NextCure shares in Q3 2021, an estimated $193K.
  • Wellington Management Group first reported a position in NextCure in Q2 2019 and held it in 8 quarters.
  • Wellington Management Group's NextCure position peaked at $33.4M in Q4 2019.
  • 71 funds tracked by Wall St. Rank held NextCure as of Q3 2021.

Based on Wellington Management Group's 13F filing for Q3 2021, filed 15 Nov 2021.